Trial no.:
|
PACTR202001690996005 |
Date of Approval:
|
21/01/2020 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Frontalis muscle flap for severe unilateral congenital ptosis correction. |
Official scientific title |
Frontalis Muscle flap versus Silicone Frontalis Sling for severe Unilateral congenital ptosis correction. |
Brief summary describing the background
and objectives of the trial
|
Congenital blepharoptosis is defined as the congenital maldevelopment of the levator palpebrae superioris musclepresent since birth. Congenital blepharoptosis does not simply cause cosmetic problems, but is also frequently associated with refractive errors, strabismus, and amblyopia, which may affect the visual function. In eyelids with poor levator function (less than 4 mm), the preferred treatment is frontalis suspension surgery, using different materials included fascia lata, and alloplastic materials (silicon, polytetrafluoroethylene, non-absorbable sutures). (5-8)It creates a direct link between the frontalis muscle and the tarsal plate of the upper eyelid, so that the frontalis muscle can be used to elevate the eyelid indirectly. However, the application of alloplastic material can be associated with the risk of foreign-body reaction and local inflammation. Autogenous fascia lata has several drawbacks such as the need for a second operative site, scarring on the leg, and difficulty to harvest from children. (9-10)
The frontalismuscle flap (FMF) advancement is considered an alternative to standard frontalis suspension. The FMF can be considered an autogenous frontalis suspensionin which the frontalis muscle is dissected and directly transposed to the upper lid tarsus. It avoids complications from the linking material such as foreign-body reaction, absorption, granuloma formation and late exposure, and the need for a second visible incision on the forehead, or any extra incisions at the donor site.(11-13)
In this study we compare the functional and aesthetic outcome of Silicone frontalis suspension versus autogenic frontalis muscle flap advancement for correction of unilateral severe congenital ptosis.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Eye Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Surgery |
Anticipated trial start date |
14/07/2019 |
Actual trial start date |
14/07/2019 |
Anticipated date of last follow up |
14/07/2021 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
30 |
Actual target sample size (number of participants) |
|
Recruitment status |
Active, not recruiting |
Publication URL |
|
|